Clinical Trials Browser

Phase 1 × Not yet recruiting × Gynecologic × Clear all

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Endometrial Neoplasms

NCT07462468 2026-03-13

A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.

Phase 1 Not yet recruiting

36 enrolled

Gynecologic

Neoplasms, Ovarian Neoplasms

NCT07383506 2026-02-03

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

Phase 1 Not yet recruiting

90 enrolled

BreastGynecologic

Breast Neoplasms, Endometrial Neoplasms

NCT07318324 2026-01-06

Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer

Phase 1 Not yet recruiting

31 enrolled

Gynecologic

Phase IB

NCT05570422 2025-09-11

A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01

Phase 1 Not yet recruiting

70 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06233331 2025-08-06

Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV

Phase 1 Not yet recruiting

9 enrolled

Gynecologic

Squamous Intraepithelial Lesions, Acquired Immunodeficiency Syndrome

NCT07088588 2025-07-28

Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors

Phase 1 Not yet recruiting

105 enrolled

BreastGynecologic

Breast Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT06846424 2025-02-26

SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

Phase 1 Not yet recruiting

24 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06760676 2025-01-07

A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy

Phase 1 Not yet recruiting

90 enrolled

GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms

NCT06754761 2025-01-01

Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib

Phase 1 Not yet recruiting

8 enrolled

GynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT06748872 2024-12-27

EPITOME-1015-I

Phase 1 Not yet recruiting

55 enrolled

GynecologicSarcoma

Carcinoma, Ovarian Epithelial, Sarcoma, Sarcoma, Synovial, Liposarcoma, Myxoid

NCT06652529 2024-11-07

AROG4-01-01

Phase 1 Not yet recruiting

35 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Mesothelioma, Ovarian Neoplasms, Colorectal Neoplasms

NCT06614751 2024-09-27

A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway

Phase 1 Not yet recruiting

112 enrolled

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06415500 2024-05-16

A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites

Phase 1 Not yet recruiting

9 enrolled

Gynecologic

Gynecologic Cancer

NCT06358053 2024-04-10

CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers

Phase 1 Not yet recruiting

24 enrolled

GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms

Clinical Trials

A Phase 1 Study of the Safety and Tolerability of CTX-10726

A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer

A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01

Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV

Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors

SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy

Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib

EPITOME-1015-I

AROG4-01-01

A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway

A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites

CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers